WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 414572

CAS#: 154082-13-0

Description: Omocianine is a non-specific, cyanine-based, fluorescent dye which is administered through intravenous (IV) injection.

Chemical Structure

CAS# 154082-13-0

Theoretical Analysis

MedKoo Cat#: 414572
Name: Omocianine
CAS#: 154082-13-0
Chemical Formula: C96H111N6O36S123-
Exact Mass: 2307.3704
Molecular Weight: 2309.67
Elemental Analysis: C, 49.92; H, 4.84; N, 3.64; O, 24.94; S, 16.66

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: Omocianine; ZK203468; ZK-203468; ZK 203468

IUPAC/Chemical Name: Trihydrogen 2-((1E,3E,5E)-7-((2E)-3,3-dimethyl-5-sulfonato-1-(2-sulfonatoethyl)-1,3-dihydro-2H-indol-2-ylidene)-4-methylhepta-1,3,5-trienyl)-3,3-dimethyl-1-(2-sulfonatoethyl)-3H-indolium-5-sulfonate


InChi Code: InChI=1S/3C32H38N2O12S4/c3*1-22(8-6-10-29-31(2,3)25-20-23(49(41,42)43)12-14-27(25)33(29)16-18-47(35,36)37)9-7-11-30-32(4,5)26-21-24(50(44,45)46)13-15-28(26)34(30)17-19-48(38,39)40/h3*6-15,20-21H,16-19H2,1-5H3,(H3-,35,36,37,38,39,40,41,42,43,44,45,46)/p-3

SMILES Code: O=S(C1=CC2=C([N+](CCS(=O)([O-])=O)=C(/C=C/C=C(C)/C=C/C=C3N(CCS(=O)([O-])=O)C4=C(C=C(S(=O)([O-])=O)C=C4)C/3(C)C)C2(C)C)C=C1)(O)=O.O=S(C5=CC6=C([N+](CCS(=O)([O-])=O)=C(/C=C/C=C(C)/C=C/C=C7N(CCS(=O)([O-])=O)C8=C(C=C(S(=O)([O-])=O)C=C8)C/7(C)C)C6(C)C)C=C5)(O)=O.O=S(C9=CC%10=C([N+](CCS(=O)([O-])=O)=C(/C=C/C=C(C)/C=C/C=C%11N(CCS(=O)([O-])=O)C%12=C(C=C(S(=O)([O-])=O)C=C%12)C/%11(C)C)C%10(C)C)C=C9)(O)=O.[H+].[H+].[H+]

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: To be determined

Shelf Life: >2 years if stored properly

Drug Formulation: To be determined

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

Preparing Stock Solutions

The following data is based on the product molecular weight 2309.67 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.


Dilution Calculator

Calculate the dilution required to prepare a stock solution.

1: Poellinger A, Persigehl T, Mahler M, Bahner M, Ponder SL, Diekmann F, Bremer C, Moesta T. Near-infrared imaging of the breast using omocianine as a fluorescent dye: results of a placebo-controlled, clinical, multicenter trial. Invest Radiol. 2011 Nov;46(11):697-704. doi: 10.1097/RLI.0b013e318229ff25. PMID: 21788905.

2: Grosenick D, Bremer C. Fluorescence Imaging of Breast Tumors and Gastrointestinal Cancer. Recent Results Cancer Res. 2020;216:591-624. doi: 10.1007/978-3-030-42618-7_18. PMID: 32594400.

3: Poellinger A. Near-infrared imaging of breast cancer using optical contrast agents. J Biophotonics. 2012 Nov;5(11-12):815-26. doi: 10.1002/jbio.201200123. PMID: 23132668.

4: van de Ven S, Wiethoff A, Nielsen T, Brendel B, van der Voort M, Nachabe R, Van der Mark M, Van Beek M, Bakker L, Fels L, Elias S, Luijten P, Mali W. A novel fluorescent imaging agent for diffuse optical tomography of the breast: first clinical experience in patients. Mol Imaging Biol. 2010 Jun;12(3):343-8. doi: 10.1007/s11307-009-0269-1. Epub 2009 Oct 2. PMID: 19798535; PMCID: PMC2864903.